As of 2024-07-27, the Relative Valuation of ImmunoGen Inc (IMGN) is (8.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -126.1%.
The range of the Relative Valuation is (8.26) - (8.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 38.2x | 31.8x |
| Forward P/E multiples | 27.6x - 30.5x | 30.1x |
| Fair Price | (8.26) - (8.04) | (8.14) |
| Upside | -126.5% - -125.7% | -126.1% |
| Date | P/E |